MedChem Module 4 Lecture 4.6

Introduction to Phase I Enzymes

  • Presenter: Wenjun Xie, Assistant Professor in the Department of Medicinal Chemistry at UF.
  • This lecture discusses Phase I enzymes, following a previous discussion on cytochrome P450 (CYP450).
  • Importance of Phase I Enzymes: Catalyze essential chemical reactions for drug metabolism.

Flavin Mono Oxygenase (FMO)

  • Definition: FMO is a mono oxygenase enzyme that catalyzes the introduction of an oxygen atom to substrates.
  • Comparison to P450: FMO is similar to P450 in function (it is also a mono oxygenase) and is membrane-bound, allowing closer proximity to lipophilic drugs.
  • Key Characteristics:
    • FMO mainly contributes to drug metabolism but has fewer isoforms (only five: FMO1, FMO2, FMO3, FMO4, FMO5).
    • It catalyzes oxidation reactions involving heteroatoms like oxygen, nitrogen, sulfur, and phosphorus in organic molecules.
  • Flavin Group's Role:
    • The flavin group facilitates electron transfer from the cofactor (NADPH).
    • Differs from P450 enzymes which require coupling with a reductase.

Mechanism of Action of FMO

  • Example with Chlorpyrifos:
    • Substrates: FMO can oxidize sulfur and nitrogen heteroatoms in chlorpyrifos, especially adding oxygen atoms from molecular oxygen to reactions involving these atoms (marked in red).

Dehydrogenases in Phase I Drug Metabolism

  • Definition: Dehydrogenases are another class of enzymes involved in Phase I reactions.
  • Types of Dehydrogenases:
    • Alcohol dehydrogenase (ADH): Acts on alcohols.
    • Aldehyde dehydrogenase (ALDH): Acts on aldehydes.
  • Cofactors Required: Can utilize either NADH or NADPH (difference is a phosphate group).
  • Differences in Reaction:
    • Alcohol Dehydrogenase: No introduction of new oxygen.
    • Aldehyde Dehydrogenase: Introduces a new oxygen atom, transforming aldehyde to carboxylic acid.
  • Location of Enzymes: Typically found in cell plasma, as substrates are more hydrophilic (e.g., alcohols and aldehydes). No need for being membrane-bound.
  • Impact of Inefficient ALDH in Certain Populations:
    • Some individuals, particularly in Asian populations, have inefficient ALDH leading to accumulation of acetaldehyde (a toxic byproduct causing flushing and headaches).

Monoamine Oxidase (MAO)

  • Definition: Enzyme that catalyzes oxidizing reactions for nitrogen-containing drugs (amines).
  • Function: MAO found in mitochondria and brain tissues; regulates neurotransmitter activity.
  • Cofactors: Requires NADH for its reactions.
  • Example Reaction: Converts amine groups to ketones and ammonia.
  • Negative Implications:
    • MAO can catalyze the formation of toxic metabolites leading to neurological disorders, such as in Parkinson's disease (e.g., conversion of MTTP to harmful byproducts).

Summary of Phase I Enzymes

  • Cytochrome P450 (CYP450): Most versatile enzyme, with over 50 members involved in various oxidation reactions (hydroxylation, epoxylation, desaturation, dehalogenation).
  • FMO: Adds oxygen to heteroatoms; fewer isoforms compared to P450, representing a small fraction of overall metabolism.
  • Dehydrogenases:
    • ADH for alcohol, ALDH for aldehyde, both important for alcohol digestion and metabolism.
  • MAO: Modulates neurotransmitter levels, potential to generate toxic compounds.
  • Statistics on Reactions:
    • CYP450 catalyzes 75-80% of Phase I reactions, with CYP3A4 alone accounting for 40% and others (CYP2D6, CYP2C9, CYP2C19) contributing about 10% each.
    • Esterases and epoxide hydrolases contribute 5-10%.
    • Though fewer in number, other enzymes are crucial for maintaining metabolic balance.
  • Role in Drug Development: Enzymes in drug metabolism enhance water solubility which is vital for subsequent phases of biotransformation (Phase II and Phase III).
  • Following lectures will cover Phase II and Phase III metabolism.

Hydrolysis in Phase I Metabolism

  • Key Concept: Hydrolysis is another major category of Phase I drug metabolism reactions involving various substrates.
    • Ester Hydrolysis:
    • Definition: An ester bond (formed from carboxylic acid and a hydroxyl group) can easily be hydrolyzed by esterase.
    • Example: Procaine (ester) can be broken down by esterase into acid and hydroxyl components.
    • Amide Hydrolysis:
    • Stronger and more resistant than esters; requires specific enzymes for hydrolysis.
    • Example: Acetaminophen is hydrolyzed into acetic acid and an amine group by amidases.
    • Peptide Hydrolysis:
    • Peptide bonds (special amid bonds) form proteins comprising amino acids.
    • Importance: Peptidases are crucial for protein digestion; they need to be highly specific to prevent excess degradation of essential proteins.
    • Example: Hydrolysis of aspartame (a sweetener) into its amino acid components.
    • Epoxide Hydrolysis:
    • Epoxides (3-membered oxygen-containing rings) can be hydrolyzed by epoxide hydrolase enzymes.
    • Two forms exist: microsomal and cytosolic; both catalyze the addition of water to open the epoxide ring.

Reduction Reactions in Phase I Metabolism

  • Context: Reduction reactions in drug metabolism are less common due to the higher presence of molecular oxygen in cells.
  • Low Oxygen Environments: Reduction mainly occurs in low oxygen environments like the intestinal tract where bacteria can facilitate these reactions.
  • **Example Types of Reduction:
    • Nitrile to Amino Group:** Catalyzed by nitrile reductase using NADPH.
    • Azo to Amino Group: Azo compounds can convert to amino groups through similar reducing reactions.

General Summary of Phase I Drug Metabolism

  • Functional Role: Phase I drug metabolism primarily serves to functionalize molecules to prepare them for the next metabolism stages.
  • Prevalence of Oxidation: Most reactions involve oxidation, with hydrolysis as a significant follow-up reaction.
  • Commonality of Reduction: Reduction is much rarer and localized to specific areas within the body.
  • Cohesive Role of Enzymes: All Phase I enzymes are critical for processing drugs and preventing toxic accumulation.
  • Acknowledgment of Future Lectures: Further exploration into Phase II and III drug metabolism will follow.
  • Conclusion: Understanding enzyme roles in Phase I drug metabolism lays the foundation for comprehending broader pharmacokinetics and drug action.